Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42841,239,1.15 [0.97-1.37],0.1004236917467871
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",44323,336,1.12 [0.97-1.30],0.1211722742617196
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43873,2321,1.10 [1.04-1.16],0.0008473627758595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Candidiasis,44361,722,1.06 [0.96-1.17],0.2298676491351317
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43014,5935,1.08 [1.05-1.12],5.77903126506409e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43204,5390,1.06 [1.02-1.09],0.0031648221421778
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43929,2051,1.11 [1.05-1.18],0.0005157473131233
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,44202,148,1.08 [0.87-1.35],0.4777329505425741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40889,1610,1.09 [1.02-1.17],0.0081857434226284
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,39457,1791,1.10 [1.04-1.18],0.0019104568260848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,39327,423,1.11 [0.97-1.26],0.1270795249813186
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,31149,3325,1.07 [1.02-1.13],0.0028047713855884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,39077,650,1.19 [1.08-1.32],0.0007938006799625
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,44291,2413,1.10 [1.04-1.16],0.0004413308164672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,44490,851,1.08 [0.98-1.18],0.1185704044970972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,43107,1555,1.11 [1.04-1.18],0.0029531064404206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,44379,1777,1.08 [1.02-1.15],0.0144768816141361
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,42216,338,1.12 [0.97-1.29],0.1304027623440231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,44581,81,1.06 [0.79-1.42],0.6986075281674933
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,44156,1554,1.07 [1.00-1.15],0.035356208586743
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,44184,130,1.19 [0.95-1.50],0.1361417958217373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,44435,262,1.27 [1.08-1.49],0.003773776895744
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",44405,232,1.26 [1.06-1.49],0.008492897881631
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,42244,692,1.19 [1.08-1.32],0.0005208129751002
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,42015,463,1.03 [0.91-1.16],0.6544478643237944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,42047,169,1.21 [0.99-1.48],0.0644731267512954
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,44539,93,0.98 [0.74-1.29],0.880642108435434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,44463,269,0.97 [0.83-1.15],0.743901976758695
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral warts,44283,89,1.00 [0.75-1.32],0.9893780920845864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],44310,116,0.98 [0.76-1.26],0.86622469467139
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,44070,506,1.04 [0.92-1.17],0.542469819258216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,44429,101,1.14 [0.88-1.48],0.3230427340691946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,44386,108,1.27 [0.99-1.63],0.0571396147705057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20455,109,0.93 [0.72-1.21],0.5978281602394937
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43999,2465,1.00 [0.95-1.06],0.907116055765015
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of meninges,44556,102,1.25 [0.96-1.62],0.0939927217124056
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,44468,120,1.03 [0.81-1.31],0.8329086400206495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,44535,181,1.10 [0.90-1.34],0.349254713084431
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of ovary,24018,150,1.13 [0.91-1.40],0.264859803021737
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Ascending colon,44538,631,0.97 [0.87-1.08],0.5611397706033574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Caecum,44546,515,1.02 [0.90-1.14],0.7855363091138985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",44388,122,1.01 [0.79-1.28],0.9612335466676912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Descending colon,44539,380,0.95 [0.83-1.09],0.4495004059591924
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,44459,611,0.96 [0.86-1.07],0.437073586363756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,44373,1076,1.00 [0.92-1.08],0.9252678557887416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Transverse colon,44529,723,1.00 [0.90-1.10],0.9278683722939276
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Carcinoma in situ of breast,19495,120,0.72 [0.56-0.92],0.0092311487570187
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19568,141,0.89 [0.71-1.11],0.2986522146231443
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",35512,93,1.27 [0.97-1.67],0.0824779433342941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",35539,120,0.88 [0.69-1.13],0.3100999227831473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",44487,206,0.90 [0.75-1.08],0.2608762660552062
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",44488,201,0.90 [0.75-1.09],0.2812599300460677
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,23218,506,1.01 [0.90-1.14],0.8782694125968878
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lung cancer and mesothelioma,30964,592,1.06 [0.95-1.19],0.3098859213144719
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Lymphoid leukaemia,35511,92,1.42 [1.09-1.87],0.0104599602515943
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35744,325,1.08 [0.93-1.25],0.2910685013048767
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35757,338,0.98 [0.85-1.14],0.7935831690540098
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19698,167,0.94 [0.77-1.16],0.5708423035595158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",35559,140,0.96 [0.77-1.21],0.7390086098259023
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",35596,177,1.14 [0.94-1.40],0.1860553082495167
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",35594,175,1.07 [0.88-1.31],0.4920067778279888
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19662,131,1.05 [0.83-1.32],0.7040347430028169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",35583,164,1.03 [0.84-1.27],0.7730516058536309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17072,1184,0.96 [0.88-1.03],0.2675249699353469
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35621,202,0.97 [0.80-1.17],0.7122680934011172
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",35550,131,1.28 [1.02-1.61],0.0325482001807127
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,35598,179,1.05 [0.86-1.28],0.6576400323937379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,44244,353,1.12 [0.98-1.29],0.1026311708750925
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of trunk,44515,153,1.20 [0.97-1.48],0.0884040534565509
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanoma in situ,35477,140,1.24 [0.99-1.54],0.0610455491844327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",35579,160,0.94 [0.76-1.16],0.5370140394541192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35697,278,1.10 [0.94-1.29],0.2185434847206501
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35825,406,0.94 [0.83-1.08],0.3925292788642864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",35592,173,1.16 [0.95-1.42],0.1392976700599613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,44273,281,1.03 [0.88-1.21],0.7078780506662117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",37256,1837,0.97 [0.91-1.03],0.3104966564902436
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",37354,1935,0.98 [0.92-1.04],0.442957746915152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,44064,592,1.07 [0.96-1.19],0.2381496743879873
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,41386,154,1.06 [0.86-1.31],0.58995865968197
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,43600,128,1.25 [0.99-1.57],0.0565978241383963
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,43241,4896,1.09 [1.05-1.13],1.630967124411679e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,42115,80,1.32 [0.99-1.77],0.0617598786267947
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43878,88,1.24 [0.93-1.64],0.136705983167852
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43769,2537,1.08 [1.02-1.14],0.0056312531404222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43767,2535,1.08 [1.02-1.13],0.0063977595581646
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,41380,148,0.97 [0.78-1.21],0.7930128803339361
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,44031,1996,1.18 [1.12-1.26],1.9013869202922057e-08
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43985,195,1.04 [0.86-1.26],0.6528149941578681
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,43578,106,1.06 [0.81-1.37],0.6777237663954785
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,43582,110,1.16 [0.91-1.49],0.2371920805237638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,44253,463,0.90 [0.79-1.02],0.0873841781535183
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,44405,92,1.22 [0.93-1.60],0.1450387208382244
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",44173,383,0.78 [0.68-0.89],0.0003923702985215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,42210,175,1.13 [0.92-1.37],0.2450357513185138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34607,515,1.07 [0.95-1.20],0.2807125024102863
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,41570,194,1.21 [1.00-1.47],0.0458514831636372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,41594,218,1.17 [0.98-1.40],0.0757834471373597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,34187,95,1.30 [1.00-1.70],0.0543473934955952
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,41433,107,1.06 [0.82-1.37],0.6489491175950752
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,40493,393,0.94 [0.82-1.07],0.3492594819209139
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43800,906,0.98 [0.89-1.07],0.5936582852598871
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,43355,461,0.89 [0.78-1.01],0.0693392918601592
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,43072,178,1.11 [0.91-1.36],0.302776198408207
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43985,2659,1.08 [1.03-1.14],0.0022942524144699
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38942,2590,1.09 [1.03-1.15],0.001444141140429
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",34201,109,1.02 [0.79-1.32],0.881811139278803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",41204,137,1.00 [0.79-1.25],0.9722720805369476
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34558,466,1.19 [1.05-1.34],0.005745801782854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,34196,104,1.16 [0.90-1.51],0.2487164331394955
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40142,6050,1.10 [1.07-1.14],2.4496386468825937e-08
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,34429,337,1.04 [0.90-1.20],0.6355276119383845
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,35029,937,1.12 [1.03-1.22],0.009352654574481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,44446,539,1.13 [1.01-1.26],0.0342554503291641
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,44124,217,1.16 [0.97-1.39],0.0994918689305757
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,34310,218,1.23 [1.03-1.47],0.0215847658114765
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",34196,104,1.18 [0.91-1.53],0.218079421106906
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,43666,2599,1.05 [1.00-1.11],0.0595063203755324
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,34521,429,1.16 [1.02-1.32],0.0214320795052978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34555,463,1.06 [0.94-1.20],0.3533164889347289
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",35171,1079,1.10 [1.01-1.19],0.0242786405102413
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,34278,186,0.99 [0.82-1.21],0.9520294518896528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,44114,207,1.16 [0.96-1.39],0.1173021524558664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,35119,1027,1.09 [1.00-1.18],0.0430845862443073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34920,828,1.12 [1.02-1.23],0.0177715041493013
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,40212,112,1.14 [0.89-1.46],0.3128509928184406
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42615,8523,1.08 [1.05-1.11],1.2559367645423933e-07
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,41144,77,0.96 [0.71-1.30],0.7824707394876507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,41166,99,1.05 [0.80-1.36],0.7339327394063955
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,44273,3305,0.98 [0.94-1.03],0.4062096877837416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",44273,3299,0.98 [0.94-1.03],0.4258541862043808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,41153,86,1.23 [0.93-1.64],0.1429492457510226
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43988,2070,1.07 [1.01-1.13],0.0331632610685348
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36752,2660,1.09 [1.04-1.15],0.0007242039018118
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,44561,357,1.04 [0.90-1.20],0.5790383276522584
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,43021,127,0.98 [0.78-1.25],0.89403202952371
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,42102,184,0.97 [0.80-1.18],0.7751452855262848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,42162,244,1.16 [0.98-1.38],0.0784310706690231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",34369,277,1.23 [1.05-1.44],0.0099742011718134
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40592,264,1.16 [0.99-1.36],0.0665490371410399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3659,142,1.07 [0.85-1.34],0.5732226847975853
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3890,418,1.01 [0.89-1.16],0.8382362207569115
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,40433,105,1.26 [0.98-1.62],0.0663906155252933
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3600,84,1.02 [0.76-1.38],0.8784219601474911
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,43518,3190,1.12 [1.06-1.17],4.160684202314724e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,43467,573,0.88 [0.78-0.98],0.0217651730969538
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40719,619,1.07 [0.96-1.19],0.2042076027029783
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,35359,1267,1.10 [1.02-1.18],0.012915989846622
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",44385,417,0.84 [0.74-0.96],0.010818154603901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),42657,275,0.87 [0.74-1.03],0.1064882723756192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,40769,2023,1.06 [1.00-1.12],0.0535424087980259
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Aortic aneurysm,42790,408,0.90 [0.78-1.03],0.1130743038848777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,42482,100,1.21 [0.93-1.57],0.1567933724513764
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",42715,333,1.17 [1.01-1.35],0.0328790403852813
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27631,3226,0.97 [0.93-1.02],0.2546974459134801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,AV-block,37658,724,0.96 [0.87-1.06],0.4321004763975649
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",44480,708,0.95 [0.86-1.05],0.3149048654595373
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiac arrest,24727,322,1.20 [1.04-1.39],0.013955948467888
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,37230,296,0.88 [0.75-1.02],0.0983898123602383
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",37099,165,0.92 [0.75-1.14],0.4509017110701432
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,44577,76,0.87 [0.64-1.18],0.3726797947113229
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,38710,1776,1.00 [0.94-1.07],0.8847690712227274
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,42264,3550,1.07 [1.02-1.12],0.0047517082473294
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,39027,13117,1.04 [1.01-1.06],0.001834158239691
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,42211,451,0.86 [0.76-0.98],0.0229456967474014
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Endocarditis,37052,118,0.94 [0.73-1.20],0.6125081997733249
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",44224,1857,1.09 [1.03-1.16],0.0057024715493175
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,40593,11224,1.05 [1.02-1.07],0.000319317313179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",40607,11238,1.05 [1.02-1.07],0.0003141928188046
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, portal",44279,134,0.72 [0.57-0.92],0.0073260133165828
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29695,326,1.14 [0.99-1.33],0.0739692208821546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29540,171,1.22 [1.00-1.49],0.0543939764334602
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,44335,1941,1.06 [0.99-1.12],0.080062803526382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,43023,185,0.90 [0.74-1.09],0.2722640707873879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",42569,3823,1.07 [1.02-1.11],0.0032085237839355
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43959,958,1.05 [0.97-1.15],0.2373206767825806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Left bundle-branch block,37551,617,1.10 [0.99-1.22],0.0857191852739533
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43795,1442,1.08 [1.00-1.15],0.0422010641410796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39962,1216,1.12 [1.04-1.20],0.0042424298720688
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",44420,270,1.20 [1.02-1.41],0.0253284272219216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",44529,529,1.07 [0.96-1.21],0.2266165075693282
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Oesophageal varices,41849,89,0.75 [0.56-1.01],0.0564257678809576
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other aneurysm,42511,129,0.97 [0.76-1.22],0.7791634350600242
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,37660,726,1.05 [0.95-1.15],0.3803648430458999
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,42557,175,1.22 [1.00-1.49],0.0470321745148546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42786,404,1.04 [0.91-1.19],0.5675412480680169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,37237,303,0.98 [0.84-1.14],0.7708387938495063
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other disorders of veins,41914,154,1.03 [0.83-1.28],0.7739842501295182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41845,85,1.02 [0.76-1.36],0.9012253287216572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,42162,107,1.01 [0.78-1.30],0.9614020526361252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41986,226,0.96 [0.80-1.15],0.669622024514736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,38664,1730,1.04 [0.97-1.11],0.2625945157483261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,42486,92,0.84 [0.63-1.11],0.223066980663728
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,43302,920,1.05 [0.97-1.15],0.2392758562459435
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43518,606,1.12 [1.01-1.25],0.0379131430265239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",43083,1028,1.06 [0.97-1.15],0.1987784209175773
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24971,566,0.99 [0.89-1.11],0.8832993567975548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,43007,678,1.10 [0.99-1.22],0.0647985734515954
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),42343,583,0.89 [0.80-1.00],0.0444657491396596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43722,810,1.02 [0.92-1.12],0.7446642484631527
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,44453,1098,1.04 [0.96-1.12],0.3870538512728898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Right bundle-branch block,37522,588,0.99 [0.89-1.11],0.8598006310859598
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43510,598,1.13 [1.01-1.25],0.0324882885825482
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,42376,321,0.97 [0.84-1.13],0.7393164194755271
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43936,1098,1.03 [0.95-1.12],0.4829036781482977
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43901,1164,1.03 [0.95-1.11],0.5274691789802424
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42976,102,0.96 [0.74-1.25],0.7573793735519205
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,42515,134,0.88 [0.70-1.12],0.2967176512391938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,43385,384,1.10 [0.96-1.26],0.1791338294136639
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42792,439,1.05 [0.92-1.19],0.4607287793758211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,42475,715,1.00 [0.90-1.10],0.9216706398883578
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,42407,144,0.90 [0.72-1.12],0.3435840393993454
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,44184,1270,0.96 [0.89-1.03],0.2778729916966731
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",44365,616,1.07 [0.97-1.19],0.1902309753166962
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",39074,2446,1.08 [1.03-1.14],0.0038803053214371
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,43455,6827,1.05 [1.02-1.08],0.0031167559035626
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",44284,720,1.07 [0.97-1.18],0.2007286029642433
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",39339,2711,1.09 [1.04-1.15],0.0008712117746953
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36769,141,0.97 [0.77-1.21],0.7758387056712732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,43655,2363,1.07 [1.01-1.13],0.0190237959716219
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",39426,2798,1.06 [1.01-1.11],0.0218171382158053
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Vascular dementia,43762,216,0.88 [0.73-1.06],0.1690428355007548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Alzheimer disease,44579,573,0.90 [0.80-1.01],0.0646583169216736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",30247,101,0.97 [0.74-1.28],0.8408411987840856
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Bell's palsy,41522,139,0.97 [0.78-1.22],0.8230908999749651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,42236,853,1.06 [0.97-1.16],0.2018912901964239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral cysts,43886,385,1.06 [0.93-1.22],0.3812502024380158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,44438,530,0.94 [0.84-1.06],0.2923756533619165
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,43744,94,1.02 [0.77-1.34],0.914420694878016
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,44552,112,1.04 [0.81-1.34],0.7301262191219431
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",43619,118,1.08 [0.84-1.38],0.5462939127550941
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,41936,484,1.00 [0.89-1.13],0.9815281698317389
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43763,2311,1.06 [1.00-1.12],0.0490874662215676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,44502,710,0.99 [0.89-1.09],0.77122531141796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,43566,4357,0.98 [0.94-1.02],0.4142929421567092
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Generalized epilepsy,43936,92,1.24 [0.95-1.63],0.1150681676448426
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,44324,416,0.98 [0.86-1.11],0.736751276010673
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hydrocephalus,43606,105,1.19 [0.92-1.54],0.1780467709834754
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,44546,121,1.25 [0.99-1.58],0.0624560904321951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,41515,132,0.84 [0.66-1.06],0.1329127048904511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,41520,137,1.06 [0.84-1.33],0.6312816858024921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Memory loss,43513,199,1.03 [0.85-1.24],0.7854586392249635
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,42061,609,1.13 [1.02-1.26],0.0202889321473397
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",44461,552,1.13 [1.01-1.26],0.03563732037057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Motor neuron disease,30439,255,1.09 [0.92-1.29],0.31093757286948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,44274,185,0.97 [0.80-1.18],0.7570296199843953
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",43428,2045,1.04 [0.98-1.10],0.1716827168737235
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,42017,6248,1.03 [0.99-1.06],0.1389339694140423
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43963,313,1.00 [0.86-1.16],0.971528853359566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",42070,687,1.07 [0.97-1.18],0.1886948507238932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",44448,492,1.13 [1.00-1.27],0.0470106892558771
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35680,1098,0.97 [0.89-1.05],0.3974403407047605
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,43624,123,0.99 [0.78-1.26],0.961289407400318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other disorders of nervous system,43741,240,0.94 [0.79-1.12],0.513141788728075
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,44042,250,1.01 [0.85-1.19],0.9216183892894232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other facial nerve disorders,41547,164,0.95 [0.77-1.16],0.5959844649602045
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other headache syndromes,41554,102,1.04 [0.80-1.35],0.7737171627193377
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,44377,876,1.08 [0.99-1.18],0.0946490747778444
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,42399,947,1.04 [0.96-1.13],0.3489624441892403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Parkinson's disease,44535,422,0.97 [0.85-1.10],0.6006101657073704
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,43597,96,1.18 [0.90-1.54],0.2360334619830886
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Restless leg syndrome,44577,110,0.99 [0.77-1.27],0.9254835438191632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,44173,821,1.04 [0.95-1.14],0.4490622595807596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Small fibre neuropathy,44039,83,1.19 [0.89-1.59],0.2452626488715138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,44551,301,1.01 [0.86-1.18],0.917967548982004
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,41473,90,1.02 [0.77-1.35],0.8999115247796801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,44579,579,0.90 [0.80-1.01],0.0656009919598331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),43696,210,0.87 [0.72-1.05],0.1482713474311781
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,43603,167,0.91 [0.74-1.12],0.3893388769601651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43880,678,0.95 [0.86-1.06],0.359373945390448
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,44297,391,1.02 [0.89-1.16],0.8265810033041292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42854,91,1.07 [0.81-1.41],0.6319523771696689
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42865,102,1.31 [1.02-1.69],0.0369132292123725
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",44397,91,1.10 [0.83-1.45],0.4966763712013937
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,44136,253,1.02 [0.87-1.21],0.7830517965644642
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3607,90,1.03 [0.77-1.37],0.8383800587938195
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4357,165,1.04 [0.84-1.29],0.709642149994115
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,43601,165,1.16 [0.95-1.43],0.145007683235647
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,44234,1774,1.07 [1.01-1.14],0.0261163654001614
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43943,1180,0.99 [0.91-1.07],0.7570300623144427
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,43143,380,1.02 [0.89-1.16],0.8308271945996155
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",44439,1237,1.00 [0.93-1.08],0.9830139732908908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,44565,116,1.26 [0.99-1.61],0.0623331974385657
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,44315,1113,0.99 [0.91-1.07],0.803073703924492
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",44508,625,1.02 [0.92-1.13],0.727741480107321
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,44417,314,1.03 [0.89-1.20],0.701959915144168
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42867,104,1.12 [0.86-1.46],0.4075891201277324
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42878,115,1.10 [0.86-1.41],0.4399380594444929
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42859,96,0.98 [0.75-1.29],0.880178496324413
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,44421,1205,1.02 [0.94-1.10],0.6908116254925948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,43535,319,0.88 [0.76-1.03],0.110591898639964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,43284,82,0.88 [0.66-1.19],0.4211516197311199
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,44056,173,0.96 [0.78-1.17],0.6709172349549306
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,44348,465,1.03 [0.91-1.17],0.5932327637083936
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,43533,331,1.04 [0.90-1.20],0.5943003491300607
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,44290,187,1.02 [0.84-1.24],0.8578640882835896
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,44002,786,1.08 [0.98-1.18],0.1288607044554231
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,43677,241,1.05 [0.89-1.25],0.5450055299147906
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41850,3752,1.06 [1.02-1.11],0.0047122767013273
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,44292,409,1.02 [0.89-1.16],0.8062625656951958
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,44542,265,1.13 [0.96-1.33],0.1366896835222326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,43462,699,0.98 [0.89-1.09],0.7682143291308262
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,44000,117,0.89 [0.70-1.14],0.3676545484736515
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,44542,93,1.30 [0.99-1.71],0.0553119628032119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42906,143,0.87 [0.69-1.09],0.2284325945098624
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,43020,257,0.84 [0.71-1.00],0.0505271908147022
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,42660,200,1.12 [0.93-1.35],0.2308922388657072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,43301,99,1.02 [0.78-1.33],0.910681893086102
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",42574,114,0.87 [0.67-1.11],0.2622776194896266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,43365,149,0.99 [0.80-1.23],0.9401543264204756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",43542,326,1.00 [0.86-1.16],0.9758244676578528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42969,206,1.07 [0.89-1.29],0.467509507664465
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,42649,189,1.28 [1.06-1.54],0.0107814264912917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,42598,138,1.14 [0.91-1.43],0.2445563103536604
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,41159,3061,1.03 [0.98-1.08],0.3081941562181011
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42888,125,1.01 [0.79-1.28],0.9504465500369236
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,44142,706,1.05 [0.95-1.16],0.3476715778593546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,43536,100,1.01 [0.77-1.32],0.9332041441076768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),43716,280,1.10 [0.94-1.29],0.2484697159917224
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,44195,156,0.92 [0.74-1.14],0.4306746046867526
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,44503,205,1.01 [0.84-1.22],0.8800990880286083
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,44353,228,1.13 [0.95-1.34],0.1818654174066589
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,44151,112,0.96 [0.75-1.24],0.7768016534131572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,44150,111,1.03 [0.80-1.33],0.8006626901647074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,44399,1503,1.06 [0.99-1.13],0.1226103734625976
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43965,1069,1.08 [1.00-1.18],0.0495671814000106
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,43113,217,0.88 [0.73-1.05],0.161076309926407
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,43045,149,1.10 [0.89-1.36],0.3852741439476899
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute pharyngitis,44150,120,0.86 [0.67-1.09],0.2117002177141459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,44392,362,0.96 [0.83-1.10],0.5184131282354927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,44138,108,0.96 [0.74-1.24],0.754068520020977
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza,41169,199,1.09 [0.90-1.32],0.3616590862043525
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),41165,195,1.11 [0.92-1.34],0.2819728574280351
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic asthma (mode),30580,208,1.25 [1.05-1.50],0.0128252822092402
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Allergic rhinitis,44366,486,1.09 [0.97-1.23],0.1668059903866552
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32994,3081,1.08 [1.03-1.14],0.0007716993747299
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",33404,3032,1.08 [1.03-1.14],0.0008758945609514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43881,238,1.24 [1.05-1.47],0.0131124467946267
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",41108,138,1.40 [1.12-1.74],0.0028855304707121
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Bronchiectasis,38597,602,1.22 [1.10-1.36],0.0002727468867456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",38092,97,1.31 [1.01-1.70],0.045563552416425
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42826,4831,1.08 [1.04-1.12],9.489757260012352e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",42195,126,0.96 [0.76-1.22],0.7312336573671161
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,42332,263,1.15 [0.98-1.35],0.0899533171463386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",44236,2030,1.08 [1.02-1.14],0.0119454986539334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,42260,191,0.96 [0.80-1.17],0.7054873231727558
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40990,9009,1.07 [1.04-1.10],2.445607646225793e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42714,645,1.02 [0.92-1.14],0.6453984913307975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,42772,566,1.04 [0.93-1.16],0.4774804900223131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Emphysema,38542,547,1.21 [1.08-1.36],0.0006935714582569
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,42286,507,1.06 [0.94-1.20],0.3142089048098252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,44188,3218,1.08 [1.03-1.13],0.0019095089453545
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,42344,565,1.11 [0.99-1.24],0.0787414757623493
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Later onset COPD,42807,1464,1.08 [1.01-1.16],0.027754740370512
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,44554,528,1.04 [0.92-1.16],0.5510562741832268
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,42261,192,1.07 [0.88-1.29],0.4960143322030897
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,44138,1641,1.10 [1.03-1.17],0.0042598527325212
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,44164,3393,1.10 [1.05-1.15],3.2978001680080617e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,43526,1457,1.07 [1.00-1.15],0.0428810852339119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other pleural conditions,40859,88,0.97 [0.73-1.28],0.8074518650107516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,44408,701,1.08 [0.98-1.19],0.1302884287915322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,44388,2224,1.14 [1.08-1.21],3.102881389380128e-06
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,42437,1666,1.10 [1.03-1.17],0.0049564457259942
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural plaque,41044,273,1.12 [0.95-1.31],0.1756673329335544
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",43757,2787,1.07 [1.02-1.13],0.0049890047577309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,44438,412,1.04 [0.91-1.19],0.5466125171140124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pneumothorax,40981,210,1.04 [0.86-1.24],0.7100477949999204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pollen allergy,44542,413,1.08 [0.95-1.23],0.2258132186921861
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pulmonary oedema,43820,113,0.95 [0.74-1.22],0.6723421302104928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Respiratory insufficiency,30466,94,1.55 [1.19-2.02],0.0012324918596078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,44102,1605,1.09 [1.02-1.16],0.0105126822023861
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,42556,487,1.09 [0.97-1.23],0.1512445902007291
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Viral pneumonia,41385,415,1.07 [0.94-1.22],0.3230287741347462
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43906,342,1.03 [0.89-1.19],0.6636282793437437
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20601,193,0.99 [0.82-1.20],0.9449221646666351
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31580,108,1.14 [0.88-1.46],0.3259634757399459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,44297,246,0.92 [0.78-1.09],0.3522499111585698
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute gastritis,33615,147,1.08 [0.87-1.35],0.464420696340043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,41422,322,1.09 [0.94-1.27],0.2365612579249914
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute peritonitis,43763,154,1.19 [0.96-1.47],0.1075373962393343
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Alcoholic liver disease,43049,127,0.82 [0.65-1.04],0.0989934164471076
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Barrett oesophagus,34212,744,0.99 [0.90-1.10],0.8993550778846595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",41274,174,1.07 [0.88-1.31],0.4994020862217305
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43859,174,1.06 [0.87-1.30],0.5445378490106092
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,41440,340,0.98 [0.85-1.14],0.8265948370822709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,42826,1726,1.06 [1.00-1.13],0.0564091654206921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,33983,515,1.05 [0.93-1.18],0.4124592607573278
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic pancreatitis,41186,86,0.78 [0.58-1.04],0.0870184181674498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",44330,185,0.81 [0.66-0.99],0.0378030117742762
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,41832,199,1.14 [0.94-1.37],0.177966238155476
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Collagenous colitis,41685,137,0.98 [0.78-1.24],0.8900627615202604
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,44303,329,1.06 [0.91-1.22],0.4568116089315175
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,44138,2798,1.02 [0.97-1.07],0.4410745902881984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,41700,152,1.09 [0.88-1.35],0.4316120569750961
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43964,108,1.04 [0.80-1.34],0.7778334173004495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41689,141,1.20 [0.97-1.50],0.0966494325929437
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,43293,393,1.11 [0.97-1.27],0.128588081027891
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,40031,3793,1.03 [0.99-1.08],0.1353851728407959
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,44360,309,1.00 [0.86-1.16],0.9876906831589296
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,44373,1451,0.98 [0.92-1.05],0.6028427816164965
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40850,7382,1.03 [1.00-1.06],0.0743576662563975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43847,947,1.05 [0.97-1.15],0.2359421503803596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,44427,818,1.11 [1.02-1.22],0.0226976120274281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,43098,198,1.05 [0.87-1.27],0.5948946349753421
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of salivary glands,42847,109,0.98 [0.76-1.26],0.8511541277172047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,44051,2418,1.05 [0.99-1.11],0.0813738430410859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of tongue,42864,189,1.03 [0.85-1.25],0.7261249053079137
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",43529,2429,1.05 [1.00-1.11],0.058755613528331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36904,5432,1.04 [1.00-1.08],0.0294686099535027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,33805,337,1.04 [0.90-1.20],0.5834226836721839
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",44424,266,1.03 [0.88-1.22],0.690888000568677
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,44430,90,1.34 [1.02-1.76],0.0327676972176768
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,43144,222,0.87 [0.73-1.04],0.1300797144677278
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31727,255,1.10 [0.94-1.30],0.235739932049453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,34413,945,1.07 [0.98-1.16],0.1412862322007528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,34084,616,1.01 [0.90-1.12],0.9038948140777572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37750,4282,1.04 [1.00-1.09],0.0395874640951651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,34385,917,1.02 [0.94-1.12],0.6317008981605086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34519,14214,1.03 [1.01-1.05],0.0082055078293585
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,43606,1973,1.03 [0.97-1.09],0.4088946778189155
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,43007,107,0.91 [0.70-1.19],0.4984954616079092
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,33126,2149,1.05 [0.99-1.11],0.1008830243173221
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",43027,105,0.85 [0.65-1.10],0.2177969919205032
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,41771,5533,1.04 [1.00-1.08],0.0427020223968327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,44442,84,1.46 [1.11-1.92],0.0074516539819845
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impaction of intestines,31570,98,1.09 [0.83-1.42],0.5427558378295745
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,37780,1542,1.03 [0.97-1.11],0.3379964946787452
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",36410,172,1.01 [0.82-1.23],0.9526436716102956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31635,163,0.87 [0.71-1.08],0.2078988880175337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41870,237,1.17 [0.99-1.39],0.0712216024510241
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,32421,949,1.07 [0.98-1.16],0.1469272254051637
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,44533,623,1.06 [0.96-1.18],0.2550550782659382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42831,1283,1.08 [1.00-1.16],0.0376882920911261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,43260,1712,1.08 [1.01-1.15],0.0189776020586966
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33786,318,1.12 [0.97-1.30],0.1318309359577296
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,34513,1045,1.07 [0.98-1.16],0.1159798958165752
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,44488,240,1.11 [0.94-1.32],0.2271503417821298
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,36353,115,1.18 [0.92-1.51],0.1962672394621769
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33806,2334,1.03 [0.97-1.09],0.3161946061168829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41578,478,1.03 [0.91-1.16],0.6597904887205176
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,41369,269,1.03 [0.88-1.21],0.6946781798677557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,34497,3025,1.00 [0.96-1.05],0.8572442164460201
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,41117,9645,1.02 [0.99-1.04],0.2447502694119401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42833,363,1.10 [0.95-1.26],0.1962241193087618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,44104,1182,0.96 [0.89-1.04],0.3533616712805784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34608,1140,0.99 [0.92-1.07],0.8126524309310217
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of pancreas,41356,256,1.01 [0.85-1.19],0.917791661551279
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,44314,705,1.11 [1.00-1.22],0.0435201371169226
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,35087,1619,1.01 [0.95-1.08],0.7688697551343617
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,43629,1996,1.02 [0.96-1.09],0.4332895777664477
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,43202,302,0.96 [0.83-1.12],0.6440523699796437
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,34351,2879,1.02 [0.97-1.07],0.3871490148917592
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36898,3430,0.99 [0.95-1.04],0.6878932097155973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,43094,172,0.92 [0.75-1.13],0.4255718929582451
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,43050,1502,1.06 [0.99-1.14],0.0830161687801879
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",32064,592,1.03 [0.92-1.15],0.5877502070412212
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,44412,107,1.31 [1.02-1.68],0.0313225601104792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,32315,843,0.98 [0.89-1.07],0.6227347840480215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41899,266,1.16 [0.99-1.36],0.0744168740889302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Recurring oral aphthae,44557,100,0.86 [0.66-1.13],0.2856810969859036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42907,203,1.05 [0.88-1.27],0.5847429824020742
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Toxic colitis,41644,96,1.06 [0.81-1.39],0.6814517671264241
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33939,471,1.12 [0.99-1.26],0.0722182750310365
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,41823,275,1.17 [1.00-1.37],0.0497890242815082
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41779,231,1.15 [0.97-1.36],0.1125521511538994
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,36705,467,0.94 [0.83-1.07],0.353766494013905
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31777,305,0.95 [0.81-1.11],0.5049086934895473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,36680,442,1.13 [1.00-1.29],0.0490205528208237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Volvulus,31607,135,0.86 [0.68-1.08],0.2003051650451642
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,44448,493,1.02 [0.91-1.15],0.7302736981265192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,44033,137,1.03 [0.82-1.29],0.7787149504413732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,41097,278,1.03 [0.88-1.21],0.6865948684058831
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,43465,1203,1.04 [0.97-1.13],0.2868485534737777
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",42567,305,1.05 [0.90-1.22],0.5391632490817317
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,41475,656,1.02 [0.91-1.13],0.7680331490308788
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,44048,474,1.07 [0.95-1.21],0.2465225987761539
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,44396,822,1.03 [0.94-1.13],0.5345765453719334
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,43657,83,1.09 [0.82-1.45],0.5619971916325583
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41896,5480,1.02 [0.98-1.06],0.2719062407653558
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43792,754,0.95 [0.86-1.05],0.3065456278363287
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,43565,527,0.94 [0.83-1.05],0.268278570857357
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43891,1629,1.02 [0.95-1.09],0.6248385834028223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",44551,94,1.03 [0.78-1.35],0.853219979826195
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40931,112,0.98 [0.76-1.26],0.8910317350672124
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,43128,90,1.12 [0.84-1.47],0.4409062149523557
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,44030,456,1.06 [0.94-1.20],0.3438862652207042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41599,780,1.04 [0.94-1.14],0.4530700975351694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40933,114,1.03 [0.80-1.32],0.8199323043070968
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,44430,138,0.98 [0.78-1.23],0.8381031503087708
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,42568,306,1.11 [0.95-1.29],0.1841502655654561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,44224,328,0.93 [0.80-1.08],0.3577405459402971
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,43675,101,0.92 [0.70-1.21],0.5597010268501863
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40930,111,0.97 [0.75-1.25],0.8220415573765859
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,43594,2775,1.03 [0.98-1.08],0.2561216796958568
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41667,848,1.04 [0.95-1.14],0.3660302127444858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40940,121,1.03 [0.81-1.32],0.781884280831764
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,44428,532,0.99 [0.89-1.12],0.9177541142988852
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,43694,120,0.92 [0.72-1.17],0.4912016194760776
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,44331,435,0.99 [0.87-1.12],0.8692615603815556
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,44491,536,1.00 [0.89-1.12],0.9555998020826064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,41039,220,1.04 [0.87-1.24],0.671257581370206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,41280,461,0.88 [0.78-1.00],0.0497274960551641
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,44473,518,1.00 [0.89-1.12],0.9596375688627732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",41207,388,1.20 [1.05-1.37],0.0085275671931176
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,44524,232,1.10 [0.92-1.30],0.2990269713013507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,38234,188,0.91 [0.75-1.11],0.3546667606951871
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40556,9674,1.03 [1.00-1.06],0.0497820945530934
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38130,7248,1.03 [0.99-1.06],0.1073883883654009
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,38178,132,0.97 [0.77-1.22],0.7953385319573851
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38692,256,1.07 [0.90-1.26],0.4459436835600963
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38740,304,1.04 [0.89-1.21],0.624675006981366
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,44151,160,0.79 [0.64-0.98],0.0349838557798792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",38602,166,0.99 [0.80-1.21],0.8961050801351792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32830,1948,1.01 [0.95-1.07],0.7390451673711449
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",44332,326,1.01 [0.87-1.17],0.8827717492415376
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,39175,739,1.09 [0.99-1.20],0.0864351459533042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37662,12472,1.03 [1.00-1.05],0.0206350274897961
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,41179,206,0.92 [0.76-1.11],0.38194977271716
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,38308,262,1.01 [0.86-1.19],0.9006381817816561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,39040,994,1.05 [0.96-1.14],0.2793762463913261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42958,4522,1.04 [1.00-1.08],0.0568360814419022
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38522,476,1.00 [0.89-1.13],0.9806661084100052
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,38435,389,1.23 [1.08-1.40],0.0021087298575545
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,38289,243,1.11 [0.94-1.31],0.2259239106224034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,43423,121,0.94 [0.73-1.20],0.6013611104964297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33773,2891,1.04 [0.99-1.09],0.1273199303537193
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31887,1005,1.11 [1.02-1.21],0.0138051839500808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",44445,989,1.11 [1.02-1.21],0.0125015788183957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,31014,132,0.92 [0.73-1.16],0.4718694060466756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31462,580,0.88 [0.79-0.99],0.0313791362889261
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38568,522,0.98 [0.87-1.10],0.6778286657394819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31974,1092,1.02 [0.95-1.11],0.545184842560902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,38528,92,1.24 [0.94-1.63],0.1224425341439745
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,39506,1070,1.07 [0.99-1.17],0.0815898677967786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38949,513,1.07 [0.95-1.20],0.2646920260811223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31896,1014,1.01 [0.93-1.09],0.87726498418542
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,38178,132,1.25 [1.00-1.57],0.0516429940769915
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",38148,102,1.18 [0.91-1.52],0.2182596417453333
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,41096,123,1.09 [0.86-1.39],0.4613436522416239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43914,2941,1.00 [0.95-1.05],0.9137136727029026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42900,1927,1.00 [0.94-1.06],0.9472304652015404
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",44335,775,1.13 [1.03-1.25],0.0092527713904496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35167,4285,1.04 [0.99-1.08],0.0930331488825154
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30989,107,0.87 [0.67-1.12],0.278674085167057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,38205,159,1.04 [0.84-1.28],0.7171798737699845
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30974,92,0.95 [0.72-1.26],0.7202721990333203
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),31101,219,1.04 [0.87-1.24],0.7034636276837554
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,41393,420,0.92 [0.81-1.05],0.2427291012754635
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,41611,638,0.99 [0.89-1.11],0.913403812398528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,44527,172,1.13 [0.93-1.38],0.2290719218426641
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",41503,3067,1.06 [1.01-1.11],0.0191368781281158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,38216,170,1.07 [0.88-1.31],0.493698650363831
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),31126,244,0.89 [0.75-1.06],0.1855240066261023
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,39668,1232,1.06 [0.98-1.14],0.1407346771651988
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,34589,3707,1.02 [0.97-1.06],0.4135015738136027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,43462,160,1.01 [0.82-1.25],0.920441078248698
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,44547,129,1.11 [0.88-1.39],0.388014186394486
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,38185,139,1.11 [0.89-1.39],0.3590626766995288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",40170,2124,1.08 [1.02-1.14],0.0080265393853255
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,38198,152,1.03 [0.83-1.27],0.8208287923380977
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33672,2790,1.07 [1.02-1.13],0.0058287517195475
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,41172,199,0.98 [0.81-1.18],0.8174960695432874
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,38133,87,0.94 [0.70-1.25],0.6519019270471841
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38708,272,0.94 [0.80-1.11],0.4868089860180725
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38975,929,1.02 [0.93-1.11],0.6616619839247446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43924,622,1.13 [1.02-1.26],0.0205488077449496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,39412,976,1.09 [1.00-1.18],0.0493795368890978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,44355,755,1.14 [1.04-1.26],0.0069066502787786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,44542,93,1.32 [1.01-1.72],0.044161120704623
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,38374,328,0.98 [0.85-1.14],0.8151441618584883
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,35307,1294,1.09 [1.02-1.18],0.015577321712146
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,39024,978,1.03 [0.95-1.12],0.4731458785575537
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],38441,395,0.99 [0.87-1.13],0.8918073008074913
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30981,99,0.99 [0.76-1.30],0.961476219372492
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35147,4265,1.08 [1.04-1.13],0.0001566113363325
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31994,1112,1.04 [0.96-1.12],0.3555709127951049
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,43700,398,1.14 [1.00-1.31],0.0494491532762337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",44464,109,1.00 [0.78-1.29],0.9972391139419764
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40862,84,1.24 [0.93-1.66],0.1353054238080457
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,31014,132,1.09 [0.87-1.37],0.4653975236250055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,38613,177,1.14 [0.93-1.39],0.2062239194087086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31668,786,1.15 [1.05-1.26],0.0039066745019772
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38576,530,0.98 [0.88-1.10],0.7825079112455379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38873,437,1.24 [1.10-1.41],0.000650096476572
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38752,316,1.04 [0.90-1.21],0.6077841770679759
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34873,102,1.38 [1.07-1.78],0.0143023782125047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",44549,100,1.23 [0.95-1.60],0.117882867302121
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,39057,1011,0.99 [0.92-1.08],0.902508565752308
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],43468,166,1.15 [0.94-1.41],0.1692983834822935
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,42475,4429,1.03 [0.99-1.07],0.134284867156978
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",38276,230,0.94 [0.79-1.13],0.5215411189529494
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,39339,903,1.08 [0.99-1.18],0.0863452542134588
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,42114,402,1.02 [0.89-1.16],0.8203388064530677
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38774,338,1.11 [0.96-1.28],0.1501657737493361
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,41063,2627,1.02 [0.97-1.08],0.3839249606526217
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,40158,1722,1.01 [0.95-1.08],0.7925556672753189
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],38136,90,0.99 [0.75-1.31],0.930658612733872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,43554,252,1.09 [0.93-1.29],0.2942798706115301
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,38329,283,1.10 [0.94-1.29],0.2191472793285667
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,38182,136,0.85 [0.68-1.07],0.1738983268205678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30977,95,1.10 [0.84-1.44],0.5024605227190355
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,42978,2588,1.08 [1.03-1.14],0.0023765982722409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18017,86,1.14 [0.86-1.51],0.3657138668087336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23479,103,0.92 [0.70-1.19],0.5153909832089256
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,44034,544,1.09 [0.97-1.22],0.1491267325852518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,43636,146,0.92 [0.73-1.15],0.4479723567232018
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,42709,2319,1.04 [0.99-1.10],0.1489687972432739
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,44230,110,0.89 [0.68-1.15],0.3573195301964676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,44199,499,0.97 [0.86-1.10],0.6801503292458642
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,39359,396,1.01 [0.88-1.15],0.8921389035861987
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dialysis,40504,114,1.35 [1.06-1.72],0.0149466386505812
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19418,2837,1.06 [1.01-1.11],0.0298856008565306
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23666,290,0.98 [0.84-1.14],0.7884594035269973
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,18081,150,1.08 [0.87-1.34],0.5004189239983593
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18273,342,0.88 [0.76-1.02],0.1013133212619239
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18807,876,1.03 [0.95-1.13],0.4605839793966119
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,37251,9085,1.03 [1.01-1.06],0.0158514546935985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,44249,129,1.15 [0.91-1.44],0.2439875731613086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydrocele,16756,175,1.05 [0.85-1.28],0.6701884304223418
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,40339,474,1.09 [0.96-1.23],0.1655057316360983
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18814,2233,1.05 [0.99-1.11],0.09292584089652
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23600,352,1.02 [0.89-1.18],0.757859572886312
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16777,196,0.86 [0.70-1.04],0.1162993444760544
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,23673,108,0.71 [0.55-0.92],0.0105841646514681
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18201,270,1.02 [0.87-1.20],0.8051593758975232
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,39093,130,1.11 [0.88-1.40],0.3668231291673287
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20069,2138,0.99 [0.94-1.05],0.859660414108028
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16678,97,0.95 [0.72-1.24],0.695763300219497
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18051,120,1.14 [0.90-1.45],0.2744037772579147
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",44563,110,1.01 [0.79-1.31],0.912202703219356
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",44562,116,0.91 [0.71-1.17],0.4690556621006526
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42778,3815,1.04 [1.00-1.09],0.0715691408863391
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,40208,1245,1.04 [0.96-1.12],0.3565920381944322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23477,101,1.00 [0.77-1.30],0.9924916919611928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,44471,771,1.06 [0.96-1.17],0.2386431330997755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16844,263,1.00 [0.85-1.18],0.9700353495670168
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16822,241,1.08 [0.91-1.28],0.3703314210331784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16776,195,1.06 [0.87-1.28],0.5565557628978385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,44517,118,1.01 [0.79-1.30],0.9075527658368048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41873,2910,1.05 [1.00-1.11],0.0357430248162582
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23429,181,1.08 [0.89-1.31],0.4572311980208263
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18067,136,1.22 [0.97-1.53],0.0820407061396302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18269,338,1.04 [0.90-1.20],0.6080119185310018
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18035,104,1.13 [0.87-1.46],0.3500761250322382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18114,183,1.12 [0.93-1.37],0.236761560434675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,40420,555,1.08 [0.97-1.21],0.1649664312607305
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43955,255,1.13 [0.96-1.33],0.1558228280687675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18194,263,1.04 [0.89-1.23],0.6230649947870732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18023,92,0.87 [0.66-1.15],0.3411446220306949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18493,562,0.99 [0.89-1.11],0.8947799815397954
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18070,139,1.26 [1.01-1.57],0.0402868924536117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18444,513,0.96 [0.85-1.08],0.4742238571958984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,44210,90,1.05 [0.79-1.39],0.7349973370607468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16809,228,1.11 [0.93-1.32],0.2364805163467717
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,44206,4341,1.06 [1.02-1.10],0.0046642889479867
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",40068,203,1.14 [0.95-1.37],0.1593585816826189
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40587,197,1.01 [0.83-1.22],0.9550523648380624
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,43584,94,1.04 [0.79-1.36],0.7960116977206316
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,39345,382,1.11 [0.97-1.28],0.1155791206478686
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,44168,678,1.05 [0.95-1.16],0.3706569064685024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18053,122,1.00 [0.79-1.27],0.995812182033642
